Semaglutide Lowers Risk of Kidney Disease Events in Patients With Type 2 Diabetes, CKD
Semaglutide was associated with a significantly lower risk of major kidney disease events in patients with type 2 diabetes and...
events
Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with...
From robotics to tooth regrowth: Top 8 game-changing events in dentistry for 2024
Perceptive’s AI-driven robotic arm performing the world’s first fully automated dental procedure. (Photo: Perceptive) The year 2024 will be remembered...
